Gould Capital »

Emergent BioSolutions shares owned by Gould Capital

Quarter-by-quarter ownership of Emergent BioSolutions (EBS) shares owned by Gould Capital from 13F filings

Historical chart of Gould Capital investment in Emergent BioSolutions

Tip: Access up to 7 years of quarterly data

All positions including Emergent BioSolutions held by Gould Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Emergent BioSolutions by Gould Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $240 100 2.40
2023-09-30 $316 100 3.16
2023-06-30 $735 100 7.35

More positions owned by Gould Capital

Ishares 3-7 Year Treasury Bond Etf Etf (IEI)
Vanguard Total Bond Market Etf Etf (BND)
Vanguard Ftse Developed Markets Etf Etf (VEA)
Vanguard Total International Bond Etf Etf (BNDX)
Microsoft Corp Stock (MSFT)
Apple Stock (AAPL)
Intel Corp Stock (INTC)
Union Pac Corp Stock (UNP)
Spdr Gold Shares Etf (GLD)
Alphabet Inc Cap Stk Cl C Stock (GOOG)
Ishares Short Treasury Bond Etf Etf (SHV)
Caterpillar Stock (CAT)
Berkshire Hathaway Inc Del Cl B Stock (BRK.B)
Vanguard Ftse Emerging Markets Etf Etf (VWO)
Aflac Stock (AFL)

View all positions for Gould Capital

Top funds holding Emergent BioSolutions

Vanguard Group
Charles Schwab Investment Management
Millennium Management
Hotchkis and Wiley Capital Management
D. E. Shaw & Co
Two Sigma Advisers
Jacobs Levy Equity Management
Two Sigma Investments
Prescott Group Capital Management
Assenagon Asset Management
Goldman Sachs Group
Dimensional Fund Advisors
AQR Capital Management
Cubist Systematic Strategies
Values First Advisors

View all funds holding Emergent BioSolutions